Comparison of acute and long-term effects of single-dose amiodarone and verapamil for the treatment of immediate recurrences of atrial fibrillation after transthoracic cardioversion

Europace

Volumn 7, Issue 6, 2005, Pages 546-553

  Sticherling, Christian ^a   Behrens, Steffen ^b   Kamke, Wolfram ^c   Stahn, Annett ^d   Zabel, Markus ^d  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b VIVANTES HOSPITAL   (Germany)

^c Department of Cardiology   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Amiodarone; Atrial fibrillation; Cardioversion; Verapamil

Indexed keywords

AMIODARONE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MIDAZOLAM; VERAPAMIL;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE DURATION; DRUG EFFICACY; DRUG INFUSION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETREATMENT; SEDATION; SINGLE DRUG DOSE; SINUS RHYTHM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CROSS-OVER STUDIES; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RECURRENCE; VERAPAMIL;

EID: 27144511154     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1016/j.eupc.2005.05.017     Document Type: Article

References (31)

1. M.C. Wijffels C.J. Kirchhof R. Dorland M.A. Allessie Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1995 1954-1968
2. E.G. Daoud F. Bogun R. Goyal M. Harvey K.C. Man S.A. Strickberger et al. Effect of atrial fibrillation on atrial refractoriness in humans Circulation 94 1996 1600-1606
3. A. Goette C. Honeycutt J.J. Langberg Electrical remodeling in atrial fibrillation. Time course and mechanisms Circulation 94 1996 2968-2974
4. A. De Simone P. Turco C. De Matteis V. La Rocca P. Nocerino L. Greco et al. Effect of verapamil on secondary cardioversion in patients with early atrial fibrillation recurrence after electrical cardioversion Am J Cardiol 90 2002 185-187
5. A. Chugh M. Ozaydin C. Scharf S.W. Lai B. Hall P. Cheung et al. Mechanism of immediate recurrences of atrial fibrillation after resoration of sinus rhythm Pacing Cardiac Electrophysiol 27 2004 77-82
6. H. Oral B.P. Knight M. Ozaydin A. Chugh S.W. Lai C. Scharf et al. Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: Feasibility and mechanistic insights Circulation 106 2002 1256-1262
7. C. Sticherling M. Ozaydin H. Tada H. Oral F. Pelosi B.P. Knight et al. Comparison of verapamil and ibutilide for the suppression of immediate recurrences of atrial fibrillation after transthoracic cardioversion J Cardiovasc Pharmacol Ther 7 2002 155-160
8. E.G. Daoud B.P. Knight R. Weiss M. Bahu W. Paladino R. Goyal et al. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans Circulation 96 1997 1542-1550
9. R.G. Tieleman C. De Langen I.C. Van Gelder P.J. de Kam J. Grandjean K.J. Bel et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria Circulation 95 1997 1945-1953
10. A. De Simone G. Stabile D.F. Vitale P. Turco M. Di Stasio F. Petrazzuoli et al. Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion J Am Coll Cardiol 34 1999 810-814
11. E.G. Daoud J.D. Hummel R. Augostini S. Williams S.J. Kalbfleisch Effect of verapamil on immediate recurrence of atrial fibrillation J Cardiovasc Electrophysiol 11 2000 1231-1237
12. C. Sticherling W. Hsu H. Tada A.C. Bares H. Oral F. Pelosi et al. Effects of verapamil and ibutilide on atrial fibrillation and post-fibrillation atrial refractoriness J Cardiovasc Electrophysiol 13 2002 151-157
13. D. Roy M. Talajic P. Dorian S. Connolly M.J. Eisenberg M. Green et al. Amiodarone to prevent recurrence of atrial fibrillation The Canadian Trial of Atrial Fibrillation Investigators N Engl J Med 342 2000 913-920
14. S. Mittal S. Ayati K.M. Stein D. Schwartzman D. Cavlovich P.J. Tchou et al. Transthoracic cardioversion of atrial fibrillation: Comparison of rectilinear biphasic versus damped sine wave monophasic shocks Circulation 101 2000 1282-1287
15. C. Timmermans L.M. Rodriguez J.L.R.M. Smeets H.J. Wellens Immediate reinitiation of atrial fibrillation following internal atrial defibrillation J Cardiovasc Electrophysiol 9 1998 122-128
16. R.G. Tieleman I.C. Van Gelder H.J. Crijns P.J. De Kam M.P. Van Den Berg J. Haaksma et al. Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 31 1998 167-173
17. W.C. Yu Y.K. Lin C.T. Tai C.F. Tsai M.H. Hsieh C.C. Chen et al. Early recurrence of atrial fibrillation after external cardioversion Pacing Cardiovasc Electrophysiol 22 1999 1614-1619
18. T. Van Noord I.C. Van Gelder B.A. Schoonderwoerd H.J. Crijns Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone Am J Cardiol 86 2000 A1384-A1385
19. H.J. Crijns T. van Noord I.C. van Gelder Recurrence of atrial fibrillation and the need for new definitions Eur Heart J 22 2001 1769-1771
20. C. Sticherling H. Oral J. Horrocks S.P. Chough R.L. Baker M.H. Kim et al. Effects of digoxin on acute, atrial fibrillation-induced changes in atrial refractoriness Circulation 102 2000 2503-2508
21. S.P. Fynn D.M. Todd J.C. Hobbs K.L. Armstrong A.P. Fitzpatrick C.J. Garrat Effect of amiodarone on dispersion of atrial refractoriness and cycle length in patients with atrial fibrillation J Cardiovasc Electrophysiol 14 2003 485-491
22. K.J. Wirth D. Knobloch Differential effects of dofetilide, amiodarone, and class Ic drugs on left and right atrial refractoriness and left atrial vulnerability in pigs Naunyn-Schmiedebergs Arch Pharmacol 363 2001 166-174
23. S. Nattel M. Talajic M. Quantz M. DeRoode Frequency-dependent effects of amiodarone on atrioventricular nodal function and slow-channel action potentials: Evidence for calcium channel blocking activity Circulation 76 1987 442-449
24. M. Duytschaever P. Danse M. Allessie Supervulnerable phase immediately after termination of atrial fibrillation J Cardiovasc Electrophysiol 13 2002 267-275
25. Ca at physiological temperatures and relevance to action potential Am J Physiol 272 1997 H227-H235
26. S. Zhang Z. Zhou Q. Gong J.C. Machielski C.T. January Mechanism of block and identification of the verapamil binding domain to HERG potassium channels Circ Res 84 1999 989-998
27. K.A. Ellenbogen L.D. German W.G. O'Callaghan P.G. Colavita A.C. Marchese M.R. Gilbert et al. Frequency-dependent effects of verapamil on atrioventricular nodal conduction in man Circulation 72 1985 344-352
28. S. Nattel L. Liu D. St-Georges Effects of the novel antiarrhythmic agent azimilide on experimental atrial fibrillation and electrophysiological properties Cardiovasc Res 37 1998 627-635
29. A. Benardeau S. Fareh S. Nattel Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs Cardiovasc Res 50 2001 85-96
30. A. De Simone M. De Pasquale C. De Matteis M. Canciello M. Manzo L. Sabino et al. Verapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion Eur Heart J 24 2003 1425-1429
31. H. Oral J.J. Souza G.F. Michaud B.P. Knight R. Goyal S.A. Strickberger et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment N Engl J Med 340 1999 1849-1854